# FDA Inspection 1163048 - Assertio Therapeutics, Inc. - February 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/assertio-therapeutics-inc/6ff5a73e-6ea7-4df8-8a9b-76b3a31de3fe
Source feed: FDA_Inspections

> FDA Inspection 1163048 for Assertio Therapeutics, Inc. on February 22, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1163048
- Company Name: Assertio Therapeutics, Inc.
- Inspection Date: 2022-02-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1281169 - 2025-09-04](https://www.keypedia.com/records/fda_inspections/assertio-therapeutics-inc/b926f505-215f-454c-9382-a3814a147712)
- [FDA Inspection 1281169 - 2025-09-04](https://www.keypedia.com/records/fda_inspections/assertio-therapeutics-inc/196b30c3-c7d5-4a8f-90c6-74d07a4baeab)
- [FDA Inspection 1192639 - 2022-11-09](https://www.keypedia.com/records/fda_inspections/assertio-therapeutics-inc/be467e3f-860d-488a-a9f6-70132e7ae639)
- [FDA Inspection 1141337 - 2021-03-26](https://www.keypedia.com/records/fda_inspections/assertio-therapeutics-inc/a8c1c765-2722-4a9d-86b2-67dfb58abda5)
- [FDA Inspection 991565 - 2016-11-02](https://www.keypedia.com/records/fda_inspections/assertio-therapeutics-inc/c0034c20-fea7-4ce7-86ba-e7c6a6ba6ccb)

Company: https://www.keypedia.com/companies/assertio-therapeutics-inc/b3e30900-d46d-47b0-996f-f4217eecbcd2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c